New monomeric insulin and its medicinal composition and prepn process
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI C A S SHENGLONGDA BIOTECH GRP
- Publication Date
- 2004-01-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the fields of medicine and pharmacy. More specifically, the present invention relates to a novel insulin B chain, a monomeric insulin containing the B chain, a pharmaceutical composition containing the monomeric insulin, and its preparation method and use. Background technique
[0002] The incidence of diabetes is increasing year by year, and it can cause death from cardiovascular disease. It is one of the major diseases threatening human health today. Hyperglycemia is the cause of various diabetic complications, and strictly controlling the blood sugar concentration within the normal range 24 hours a day is the most critical factor to prevent and delay the complications of late diabetes.
[0003] Insulin has been an irreplaceable drug since it was used to treat diabetes in the 1920s. However, the secretion of insulin in a normal human body is regulated by the blood sugar concentration. Generally, the blood insulin co...